首页 > 最新文献

Radiology. Imaging cancer最新文献

英文 中文
Clinical Outcomes of MRI-guided Transurethral US Ablation (MRI-TULSA) of Localized Prostate Cancer. mri引导下经尿道US消融术治疗局限性前列腺癌的临床效果
IF 5.6 Q1 ONCOLOGY Pub Date : 2025-07-01 DOI: 10.1148/rycan.259015
Radhika Rajeev
{"title":"Clinical Outcomes of MRI-guided Transurethral US Ablation (MRI-TULSA) of Localized Prostate Cancer.","authors":"Radhika Rajeev","doi":"10.1148/rycan.259015","DOIUrl":"10.1148/rycan.259015","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"7 4","pages":"e259015"},"PeriodicalIF":5.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12304528/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144660035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pulmonary Cement Embolism after Percutaneous Vertebroplasty for Metastatic Rectal Cancer. 转移性直肠癌经皮椎体成形术后肺水泥栓塞。
IF 5.6 Q1 ONCOLOGY Pub Date : 2025-07-01 DOI: 10.1148/rycan.250200
Divij Agarwal, Sanjay Kumar Meena, Tej Pal, Amit Gupta, S H Chandrashekhara
{"title":"Pulmonary Cement Embolism after Percutaneous Vertebroplasty for Metastatic Rectal Cancer.","authors":"Divij Agarwal, Sanjay Kumar Meena, Tej Pal, Amit Gupta, S H Chandrashekhara","doi":"10.1148/rycan.250200","DOIUrl":"10.1148/rycan.250200","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"7 4","pages":"e250200"},"PeriodicalIF":5.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12304541/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144609217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
64Cu-labeled Nanobodies Monitor CD4+ T-Cell Populations in Response to Immunotherapy Using PET Imaging. 64cu标记纳米体监测CD4+ t细胞群对免疫治疗的反应
IF 5.6 Q1 ONCOLOGY Pub Date : 2025-07-01 DOI: 10.1148/rycan.259016
Laiba Akhtar, Wesley J Hannafon, Lacey R McNally
{"title":"<sup>64</sup>Cu-labeled Nanobodies Monitor CD4+ T-Cell Populations in Response to Immunotherapy Using PET Imaging.","authors":"Laiba Akhtar, Wesley J Hannafon, Lacey R McNally","doi":"10.1148/rycan.259016","DOIUrl":"10.1148/rycan.259016","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"7 4","pages":"e259016"},"PeriodicalIF":5.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12304529/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144708539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Pelvic Structure Involvement and Tumor Morphology at MRI with Prognosis Following Resection in Locally Recurrent Rectal Cancer. 局部复发直肠癌切除术后盆腔结构受累及MRI肿瘤形态与预后的关系。
IF 5.6 Q1 ONCOLOGY Pub Date : 2025-07-01 DOI: 10.1148/rycan.240246
Davy M J Creemers, Henrik Iversen, Evi Banken, Floor Piqeur, Stijn H J Ketelaers, Alette Daniëls-Gooszen, Gabriella J Palmer, Torbjörn Holm, Harm Rutten, Chikako Suzuki, Jacobus W A Burger, Anna Martling, Joost Nederend

Purpose To determine the influence of location, extent of tissue invasion, and tumor morphology at MRI on the resectability of locally recurrent rectal cancer (LRRC) and postresection oncologic outcomes of LRRC. Materials and Methods This retrospective observational study included consecutive patients diagnosed with LRRC who underwent surgery with curative intent at the Catharina Hospital Eindhoven and Karolinska University Hospital Stockholm between January 2003 and December 2017. Two expert radiologists reviewed available MR images while adhering to a standardized reviewing checklist. The effect of pelvic structure involvement, tumor morphology on the primary outcome of resection margin status, and secondary outcomes of overall survival and disease-free survival were assessed using univariable and multivariable logistic regression and Cox proportional hazard analyses. Results The final analysis included 328 patients with LRRC (mean age ± SD, 64.9 years ± 9.6; 126 female, 202 male). Resection margins were negative in 217 (66.2%) patients and positive in 111 patients (33.8%). Tumor size, tumor type, and border type on MR images were all associated with resectability. Central recurrences were associated with the lowest likelihood of positive resection margins (odds ratio [OR], 0.45; 95% CI: 0.28, 0.71; P < .001), whereas lateral recurrences were associated with the highest likelihood (OR, 2.00; 95% CI: 1.25, 3.19: P = .004). Similarly, central recurrences were associated with better disease-free survival compared with lateral recurrences (hazard ratio [HR], 0.69; 95% CI: 0.53, 0.90; P = .006 vs HR, 1.49; 95% CI: 1.14, 1.94; P = .003, respectively). Similar findings were observed after correcting for resection margin status. Conclusion Standardized MRI assessment of tumor characteristics in patients with LRRC resulted in the identification of specific prognostic factors. Central compartment involvement and well-defined tumors were associated with improved prognosis, whereas lateral compartment involvement and fibrotic spiculated tumors were associated with a worse prognosis after surgical resection. Keywords: Rectum, MR-Imaging, Abdomen/GI, Oncology, Surgery, Locally Recurrent Rectal Cancer, Tumor Biology Supplemental material is available for this article. © RSNA, 2025.

目的探讨局部复发直肠癌(LRRC)的部位、组织浸润程度和肿瘤MRI形态对其可切除性及术后肿瘤预后的影响。本回顾性观察性研究纳入了2003年1月至2017年12月期间在埃因霍温Catharina医院和斯德哥尔摩卡罗林斯卡大学医院连续接受手术治疗的LRRC患者。两名放射科专家在遵循标准化检查清单的同时审查了可用的MR图像。采用单变量和多变量logistic回归及Cox比例风险分析评估盆腔结构受损伤、肿瘤形态对切除边缘状态的主要结局、总生存期和无病生存期的次要结局的影响。结果最终纳入328例LRRC患者(平均年龄±SD, 64.9岁±9.6岁;126名女性,202名男性)。切缘阴性217例(66.2%),阳性111例(33.8%)。MR图像上肿瘤大小、肿瘤类型和边界类型均与可切除性相关。中枢性复发与切除边缘阳性的可能性最低相关(优势比[OR], 0.45;95% ci: 0.28, 0.71;P < 0.001),而外侧复发与最高可能性相关(OR, 2.00;95% ci: 1.25, 3.19: p = 0.004)。同样,与外侧复发相比,中心复发与更好的无病生存相关(风险比[HR], 0.69;95% ci: 0.53, 0.90;P = 0.006 vs HR, 1.49;95% ci: 1.14, 1.94;P = 0.003)。在纠正切除边缘状态后观察到类似的结果。结论对LRRC患者肿瘤特征进行标准化的MRI评估,可识别特定的预后因素。中央室受累和肿瘤界限明确与预后改善相关,而外侧室受累和纤维性针状肿瘤与手术切除后预后较差相关。关键词:直肠,磁共振成像,腹部/胃肠道,肿瘤学,外科,局部复发性直肠癌,肿瘤生物学©rsna, 2025。
{"title":"Association of Pelvic Structure Involvement and Tumor Morphology at MRI with Prognosis Following Resection in Locally Recurrent Rectal Cancer.","authors":"Davy M J Creemers, Henrik Iversen, Evi Banken, Floor Piqeur, Stijn H J Ketelaers, Alette Daniëls-Gooszen, Gabriella J Palmer, Torbjörn Holm, Harm Rutten, Chikako Suzuki, Jacobus W A Burger, Anna Martling, Joost Nederend","doi":"10.1148/rycan.240246","DOIUrl":"10.1148/rycan.240246","url":null,"abstract":"<p><p>Purpose To determine the influence of location, extent of tissue invasion, and tumor morphology at MRI on the resectability of locally recurrent rectal cancer (LRRC) and postresection oncologic outcomes of LRRC. Materials and Methods This retrospective observational study included consecutive patients diagnosed with LRRC who underwent surgery with curative intent at the Catharina Hospital Eindhoven and Karolinska University Hospital Stockholm between January 2003 and December 2017. Two expert radiologists reviewed available MR images while adhering to a standardized reviewing checklist. The effect of pelvic structure involvement, tumor morphology on the primary outcome of resection margin status, and secondary outcomes of overall survival and disease-free survival were assessed using univariable and multivariable logistic regression and Cox proportional hazard analyses. Results The final analysis included 328 patients with LRRC (mean age ± SD, 64.9 years ± 9.6; 126 female, 202 male). Resection margins were negative in 217 (66.2%) patients and positive in 111 patients (33.8%). Tumor size, tumor type, and border type on MR images were all associated with resectability. Central recurrences were associated with the lowest likelihood of positive resection margins (odds ratio [OR], 0.45; 95% CI: 0.28, 0.71; <i>P</i> < .001), whereas lateral recurrences were associated with the highest likelihood (OR, 2.00; 95% CI: 1.25, 3.19: <i>P</i> = .004). Similarly, central recurrences were associated with better disease-free survival compared with lateral recurrences (hazard ratio [HR], 0.69; 95% CI: 0.53, 0.90; <i>P</i> = .006 vs HR, 1.49; 95% CI: 1.14, 1.94; <i>P</i> = .003, respectively). Similar findings were observed after correcting for resection margin status. Conclusion Standardized MRI assessment of tumor characteristics in patients with LRRC resulted in the identification of specific prognostic factors. Central compartment involvement and well-defined tumors were associated with improved prognosis, whereas lateral compartment involvement and fibrotic spiculated tumors were associated with a worse prognosis after surgical resection. <b>Keywords:</b> Rectum, MR-Imaging, Abdomen/GI, Oncology, Surgery, Locally Recurrent Rectal Cancer, Tumor Biology <i>Supplemental material is available for this article.</i> © RSNA, 2025.</p>","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"7 4","pages":"e240246"},"PeriodicalIF":5.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12304544/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144507960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of Giant Asymptomatic Thymic Fibrolipoadenoma Using Dual-Layer Detector Spectral CT. 巨大无症状胸腺纤维脂肪腺瘤的双层探测光谱CT分析。
IF 5.6 Q1 ONCOLOGY Pub Date : 2025-07-01 DOI: 10.1148/rycan.250050
Haojie Zhang, Zhigang Zhou, Songzi Kou, Yuhan Zhou
{"title":"Analysis of Giant Asymptomatic Thymic Fibrolipoadenoma Using Dual-Layer Detector Spectral CT.","authors":"Haojie Zhang, Zhigang Zhou, Songzi Kou, Yuhan Zhou","doi":"10.1148/rycan.250050","DOIUrl":"10.1148/rycan.250050","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"7 4","pages":"e250050"},"PeriodicalIF":5.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12304527/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144333791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Digital Breast Tomosynthesis and Mammography-based Radiomics for Breast Cancer Risk Assessment: Case-Control Study. 数字乳腺断层合成和基于乳房x线摄影的放射组学用于乳腺癌风险评估的比较:病例对照研究。
IF 5.6 Q1 ONCOLOGY Pub Date : 2025-07-01 DOI: 10.1148/rycan.240318
Alex A Nguyen, Eric A Cohen, Omid Haji Maghsoudi, Raymond J Acciavatti, Lauren Pantalone, Walter C Mankowski, Christopher G Scott, Stacey Winham, Celine M Vachon, Andrew D Maidment, Emily F Conant, Anne Marie McCarthy, Despina Kontos

Purpose To compare the performance of volumetric radiomic parenchymal pattern analysis from three-dimensional (3D) digital breast tomosynthesis (DBT) images with that of two-dimensional (2D) digital mammography (DM) and 2D sections from DBT in assessing breast cancer risk relative to breast density measurements. Materials and Methods This was a retrospective matched case-control study among individuals who underwent concurrent DM and DBT screening from March 2011 through December 2014. The Cancer Phenomics Toolkit was used to calculate radiomic features from craniocaudal and mediolateral oblique views in all study patients, matched on race and age, for various experimental settings, including image resolution and window size. For each image type, conditional logistic regression evaluated the association of radiomic features, along with age, body mass index (BMI), and area percent density (PD) (from the Laboratory for Individualized Breast Radiodensity Assessment software), with breast cancer, using the C statistic as the measure of model predictive ability. Model fit was compared via likelihood ratio tests. Results The study included 924 female patients (median age, 61 years [IQR: 51-69 years]), with 187 cases and 737 controls. Volumetric features from 3D reconstructed DBT scans had, on average, higher C statistics across all experimental conditions. Among models using only radiomic features, C statistics were highest for models using features from 3D images (mean C statistic: 0.68, P < .001); models using features from 2D image types resulted in lower mean C statistics (0.60 to 0.65). A baseline model using age, BMI, and area PD had a C statistic of 0.60. The effect of higher image resolution and smaller window size were not substantial, supporting the use of less computationally intensive processing. Conclusion Fully automated 3D parenchymal analysis from DBT improved breast cancer risk estimation beyond markers derived from area breast density and 2D images. Keywords: Mammography, Tomosynthesis, Breast, Volume Analysis Supplemental material is available for this article. © RSNA, 2025.

目的比较三维(3D)数字乳腺断层合成(DBT)图像的体积放射学实质模式分析与二维(2D)数字乳房x线照相术(DM)和DBT二维切片在相对于乳腺密度测量评估乳腺癌风险方面的表现。材料和方法本研究是一项回顾性匹配病例对照研究,研究对象为2011年3月至2014年12月期间同时接受糖尿病和DBT筛查的患者。Cancer Phenomics Toolkit用于计算所有研究患者颅侧和中外侧斜位视图的放射学特征,匹配种族和年龄,各种实验设置,包括图像分辨率和窗口大小。对于每种图像类型,条件逻辑回归评估放射学特征与年龄、体重指数(BMI)和面积百分比密度(PD)(来自个体化乳腺放射密度评估软件实验室)与乳腺癌的关联,使用C统计量作为模型预测能力的度量。通过似然比检验比较模型拟合。结果纳入924例女性患者(中位年龄61岁[IQR: 51 ~ 69岁]),其中187例为病例,对照组为737例。在所有实验条件下,三维重建DBT扫描的体积特征平均具有更高的C统计值。在仅使用放射学特征的模型中,使用3D图像特征的模型的C统计量最高(平均C统计量:0.68,P < 0.001);使用2D图像类型特征的模型导致较低的平均C统计量(0.60至0.65)。使用年龄、BMI和区域PD的基线模型的C统计值为0.60。更高的图像分辨率和更小的窗口尺寸的效果并不显著,支持使用较少的计算密集型处理。结论基于DBT的全自动三维实质分析比基于区域乳腺密度和二维图像的标志物更能改善乳腺癌风险评估。关键词:乳腺x线摄影,断层合成,乳腺,体积分析本文有补充材料。©rsna, 2025。
{"title":"Comparison of Digital Breast Tomosynthesis and Mammography-based Radiomics for Breast Cancer Risk Assessment: Case-Control Study.","authors":"Alex A Nguyen, Eric A Cohen, Omid Haji Maghsoudi, Raymond J Acciavatti, Lauren Pantalone, Walter C Mankowski, Christopher G Scott, Stacey Winham, Celine M Vachon, Andrew D Maidment, Emily F Conant, Anne Marie McCarthy, Despina Kontos","doi":"10.1148/rycan.240318","DOIUrl":"10.1148/rycan.240318","url":null,"abstract":"<p><p>Purpose To compare the performance of volumetric radiomic parenchymal pattern analysis from three-dimensional (3D) digital breast tomosynthesis (DBT) images with that of two-dimensional (2D) digital mammography (DM) and 2D sections from DBT in assessing breast cancer risk relative to breast density measurements. Materials and Methods This was a retrospective matched case-control study among individuals who underwent concurrent DM and DBT screening from March 2011 through December 2014. The Cancer Phenomics Toolkit was used to calculate radiomic features from craniocaudal and mediolateral oblique views in all study patients, matched on race and age, for various experimental settings, including image resolution and window size. For each image type, conditional logistic regression evaluated the association of radiomic features, along with age, body mass index (BMI), and area percent density (PD) (from the Laboratory for Individualized Breast Radiodensity Assessment software), with breast cancer, using the C statistic as the measure of model predictive ability. Model fit was compared via likelihood ratio tests. Results The study included 924 female patients (median age, 61 years [IQR: 51-69 years]), with 187 cases and 737 controls. Volumetric features from 3D reconstructed DBT scans had, on average, higher C statistics across all experimental conditions. Among models using only radiomic features, C statistics were highest for models using features from 3D images (mean C statistic: 0.68, <i>P</i> < .001); models using features from 2D image types resulted in lower mean C statistics (0.60 to 0.65). A baseline model using age, BMI, and area PD had a C statistic of 0.60. The effect of higher image resolution and smaller window size were not substantial, supporting the use of less computationally intensive processing. Conclusion Fully automated 3D parenchymal analysis from DBT improved breast cancer risk estimation beyond markers derived from area breast density and 2D images. <b>Keywords:</b> Mammography, Tomosynthesis, Breast, Volume Analysis <i>Supplemental material is available for this article.</i> © RSNA, 2025.</p>","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"7 4","pages":"e240318"},"PeriodicalIF":5.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12304537/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144554321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The SUPE_R Trial: Posttreatment Surveillance with 18F-FDG PET/CT in Stage I to III Non-Small Cell Lung Cancer. super_r试验:18F-FDG PET/CT治疗后监测I至III期非小细胞肺癌
IF 5.6 Q1 ONCOLOGY Pub Date : 2025-07-01 DOI: 10.1148/rycan.259013
Netanja I Harlianto, Pim A de Jong
{"title":"The SUPE_R Trial: Posttreatment Surveillance with <sup>18</sup>F-FDG PET/CT in Stage I to III Non-Small Cell Lung Cancer.","authors":"Netanja I Harlianto, Pim A de Jong","doi":"10.1148/rycan.259013","DOIUrl":"10.1148/rycan.259013","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"7 4","pages":"e259013"},"PeriodicalIF":5.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12304542/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144554323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a Conversational Multimodal AI Tool for Assessing Malignancy Risk of Thyroid Nodules. 用于评估甲状腺结节恶性风险的会话式多模式人工智能工具的开发。
IF 5.6 Q1 ONCOLOGY Pub Date : 2025-07-01 DOI: 10.1148/rycan.259014
Govind S Mattay
{"title":"Development of a Conversational Multimodal AI Tool for Assessing Malignancy Risk of Thyroid Nodules.","authors":"Govind S Mattay","doi":"10.1148/rycan.259014","DOIUrl":"10.1148/rycan.259014","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"7 4","pages":"e259014"},"PeriodicalIF":5.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12304531/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144660036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiomics-based Machine Learning Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Using Physiologically Decomposed Diffusion-weighted MRI. 基于放射组学的机器学习预测乳腺癌新辅助化疗反应的生理分解扩散加权MRI。
IF 5.6 Q1 ONCOLOGY Pub Date : 2025-07-01 DOI: 10.1148/rycan.240312
Maya Gilad, Savannah C Partridge, Mami Iima, Rebecca Rakow-Penner Md, Moti Freiman

Purpose To evaluate the performance of a machine learning model developed using radiomics data derived from physiologically decomposed diffusion-weighted MRI data for predicting pathologic complete response (pCR) following neoadjuvant chemotherapy for breast cancer compared with baseline and benchmark models. Materials and Methods This retrospective study included data from the Breast Multiparametric MRI for prediction of neoadjuvant chemotherapy Response (BMMR2) challenge dataset, comprising longitudinal multiparametric breast MRI studies (diffusion-weighted imaging [DWI] and dynamic contrast-enhanced MRI) from participants enrolled in the I-SPY 2/ACRIN 6698 trial (ClinicalTrials.gov: NCT01042379). Piecewise linear physiologic decomposition was applied to DWI data (PD DWI) to isolate pseudo-diffusion, pure-diffusion, and pseudo-diffusion fraction components for radiomics feature extraction. These features were used to develop a boosted decision tree model to predict pCR following neoadjuvant chemotherapy. Model performance was compared with performance of baseline models, including data on tumor size and mean apparent diffusion coefficient, and the BMMR2 challenge benchmark model using area under the receiver operating characteristic curve, F1 score, and positive and negative predictive values. Model calibration was assessed via the Brier score, and a decision curve analysis was performed to estimate the potential reduction in unnecessary interventions when using the proposed model. Results The study included multiparametric MRI scans from 190 female participants (mean age ± SD, 48.4 years ± 10.5). PD DWI achieved the highest area under the receiver operating characteristic curve (0.89, 95% CI: 0.81, 0.96) among all evaluated models, demonstrating statistically significant improvements over baseline approaches (all P < .04). Decision curve analysis showed that the PD DWI model provided a greater net benefit compared with the BMMR2 challenge benchmark model (0.17, 95% CI: 0.13, 0.21 vs 0.09, 95% CI: 0.05, 0.13; P < .001). Conclusion A machine learning model using radiomics data derived from PD DWI achieved higher performance than baseline and benchmark models in predicting pCR following neoadjuvant chemotherapy for breast cancer. Keywords: Image Postprocessing, MR-Diffusion Weighted Imaging, Breast, Tumor Response, Experimental Investigations ClinicalTrials.gov: NCT01042379 © RSNA, 2025.

目的:与基线和基准模型相比,评估基于生理分解扩散加权MRI数据的放射组学数据开发的机器学习模型在预测乳腺癌新辅助化疗后病理完全缓解(pCR)方面的性能。本回顾性研究纳入了用于预测新辅助化疗反应(BMMR2)挑战数据集的乳腺多参数MRI数据,包括I-SPY 2/ACRIN 6698试验(ClinicalTrials.gov: NCT01042379)参与者的纵向多参数乳腺MRI研究(弥散加权成像[DWI]和动态对比增强MRI)。对DWI数据进行分段线性生理分解(PD DWI),分离伪扩散、纯扩散和伪扩散组分,提取放射组学特征。这些特征被用来开发一个增强的决策树模型来预测新辅助化疗后的pCR。将模型的性能与基线模型的性能进行比较,包括肿瘤大小和平均表观扩散系数的数据,以及BMMR2挑战基准模型的性能,包括受试者工作特征曲线下的面积、F1评分和阳性和阴性预测值。通过Brier评分评估模型校准,并进行决策曲线分析,以估计使用该模型时可能减少的不必要干预。结果本研究包括190名女性参与者(平均年龄±SD, 48.4岁±10.5岁)的多参数MRI扫描。在所有评估的模型中,PD DWI在受试者工作特征曲线下的面积最高(0.89,95% CI: 0.81, 0.96),与基线方法相比,显示出统计学上显著的改善(均P < .04)。决策曲线分析显示,PD DWI模型比BMMR2挑战基准模型提供了更大的净效益(0.17,95% CI: 0.13, 0.21 vs 0.09, 95% CI: 0.05, 0.13;P < 0.001)。结论基于PD DWI放射组学数据的机器学习模型在预测乳腺癌新辅助化疗后pCR方面的表现优于基线和基准模型。关键词:图像后处理,磁共振弥散加权成像,乳腺,肿瘤反应,实验研究ClinicalTrials.gov: NCT01042379©RSNA, 2025。
{"title":"Radiomics-based Machine Learning Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Using Physiologically Decomposed Diffusion-weighted MRI.","authors":"Maya Gilad, Savannah C Partridge, Mami Iima, Rebecca Rakow-Penner Md, Moti Freiman","doi":"10.1148/rycan.240312","DOIUrl":"10.1148/rycan.240312","url":null,"abstract":"<p><p>Purpose To evaluate the performance of a machine learning model developed using radiomics data derived from physiologically decomposed diffusion-weighted MRI data for predicting pathologic complete response (pCR) following neoadjuvant chemotherapy for breast cancer compared with baseline and benchmark models. Materials and Methods This retrospective study included data from the Breast Multiparametric MRI for prediction of neoadjuvant chemotherapy Response (BMMR2) challenge dataset, comprising longitudinal multiparametric breast MRI studies (diffusion-weighted imaging [DWI] and dynamic contrast-enhanced MRI) from participants enrolled in the I-SPY 2/ACRIN 6698 trial (ClinicalTrials.gov: NCT01042379). Piecewise linear physiologic decomposition was applied to DWI data (PD DWI) to isolate pseudo-diffusion, pure-diffusion, and pseudo-diffusion fraction components for radiomics feature extraction. These features were used to develop a boosted decision tree model to predict pCR following neoadjuvant chemotherapy. Model performance was compared with performance of baseline models, including data on tumor size and mean apparent diffusion coefficient, and the BMMR2 challenge benchmark model using area under the receiver operating characteristic curve, F1 score, and positive and negative predictive values. Model calibration was assessed via the Brier score, and a decision curve analysis was performed to estimate the potential reduction in unnecessary interventions when using the proposed model. Results The study included multiparametric MRI scans from 190 female participants (mean age ± SD, 48.4 years ± 10.5). PD DWI achieved the highest area under the receiver operating characteristic curve (0.89, 95% CI: 0.81, 0.96) among all evaluated models, demonstrating statistically significant improvements over baseline approaches (all <i>P</i> < .04). Decision curve analysis showed that the PD DWI model provided a greater net benefit compared with the BMMR2 challenge benchmark model (0.17, 95% CI: 0.13, 0.21 vs 0.09, 95% CI: 0.05, 0.13; <i>P</i> < .001). Conclusion A machine learning model using radiomics data derived from PD DWI achieved higher performance than baseline and benchmark models in predicting pCR following neoadjuvant chemotherapy for breast cancer. <b>Keywords:</b> Image Postprocessing, MR-Diffusion Weighted Imaging, Breast, Tumor Response, Experimental Investigations ClinicalTrials.gov: NCT01042379 © RSNA, 2025.</p>","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"7 4","pages":"e240312"},"PeriodicalIF":5.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12304534/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144660037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Balancing Quality and Safety: AI-denoised CT for Active Surveillance of Solid Renal Masses. 平衡质量与安全:人工智能降噪CT主动监测肾实性肿块。
IF 5.6 Q1 ONCOLOGY Pub Date : 2025-07-01 DOI: 10.1148/rycan.250263
Valdair F Muglia
{"title":"Balancing Quality and Safety: AI-denoised CT for Active Surveillance of Solid Renal Masses.","authors":"Valdair F Muglia","doi":"10.1148/rycan.250263","DOIUrl":"10.1148/rycan.250263","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"7 4","pages":"e250263"},"PeriodicalIF":5.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12304543/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144286416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Radiology. Imaging cancer
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1